95 results on '"Leurs A"'
Search Results
2. Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab
3. Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab
4. Disease activity following pregnancy-related discontinuation of natalizumab in MS
5. Deep gray matter volume loss drives disability worsening in multiple sclerosis
6. Disturbances of dental development distinguish patients with oligodontia‐ectodermal dysplasia from isolated oligodontia
7. The clinical pharmacology of non-sedating antihistamines
8. John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients
9. High cumulative JC virus seroconversion rate during long-term use of natalizumab
10. THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Overview
11. Body fluid biomarkers for multiple sclerosis—the long road to clinical application
12. Getting to the core of protein pharmaceuticals – Comprehensive structure analysis by mass spectrometry
13. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients
14. PLASMA PENTOSIDINE, MALNUTRITION AND ALL-CAUSE MORTALITY IN CKD STAGE 5 PATIENTS: O116
15. Endovascular repair of abdominal aortic aneurysm in octogenarians: An analysis based on EUROSTAR data
16. A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H3 receptor stably expressed in CHO-K1 cells
17. Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 983.36 of the human histamine H4 receptor
18. Detailed analysis of biased histamine H4 receptor signalling by JNJ 7777120 analogues
19. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design
20. Clinical evaluation of the ADE scorecards as a decision support tool for adverse drug event analysis and medication safety management
21. Caspase-14 overexpression in hairless mice is not involved in utricle formation
22. Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes
23. Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR
24. Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3
25. Pharmacological modulation of chemokine receptor function
26. Strain-dependent effects of the histamine H4 receptor antagonist JNJ7777120 in a murine model of acute skin inflammation
27. Selective histamine H3 and H4 receptor agonists exert opposite effects against the gastric lesions induced by HCl in the rat stomach
28. Agonist-dependent effects of mutations in the sphingosine-1-phosphate type 1 receptor
29. G protein-coupled receptors: walking hand-in-hand, talking hand-in-hand?
30. Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target
31. Towards evidence-based, quality-controlled health promotion: the Dutch recognition system for health promotion interventions
32. The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice
33. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-α-PGP) does not interact directly with human CXCR1 and CXCR2
34. No correlation between time-linked plasma and CSF Aβ levels
35. Activation of the histaminergic H3 receptor induces phosphorylation of the Akt/GSK-3β pathway in cultured cortical neurons and protects against neurotoxic insults
36. Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors
37. Pharmacological characterization of the new histamine H4 receptor agonist VUF 8430
38. The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS
39. Molecular and biochemical pharmacology of the histamine H4 receptor
40. Cloning and pharmacological characterization of the dog histamine H4 receptor
41. The H4 histamine receptor is functionally expressed on neurons in the mammalian CNS: S5.C002
42. Histamine receptors: from the human genome to new therapeutic options for inflammatory disorders: S5.2
43. Molecular determinants of ligand-directed signaling for the histamine H1 receptor
44. Horizontal gene transfer from human endothelial cells to rat cardiomyocytes after intracoronary transplantation
45. Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively
46. The Akt/GSK-3β axis as a new signaling pathway of the histamine H3 receptor
47. Histamine downregulates monocyte CCL2 production through the histamine H4 receptor
48. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons
49. Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation
50. Molecular aspects of the histamine H3 receptor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.